首页> 外文OA文献 >Most primary adrenal lymphomas are diffuse large B-cell lymphomas with non-germinal center B-cell phenotype, BCL6 gene rearrangement and poor prognosis

【2h】

Most primary adrenal lymphomas are diffuse large B-cell lymphomas with non-germinal center B-cell phenotype, BCL6 gene rearrangement and poor prognosis

机译：大多数主要肾上腺淋巴瘤是弥漫性大B细胞淋巴瘤，具有非生发中心B细胞表型，BCL6基因重排和预后差

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Ana Mozos; Hongtao Ye; Wen-Yu Chuang; Jan-Show Chu; Wan-Ting Huang; Han-Ku Chen; Yung-Hsiang Hsu; Chris M Bacon; Ming-Qing Du; Elias Campo; Shih-Sung Chuang;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Most primary adrenal lymphomas are diffuse large B-cell lymphomas with non-germinal center B-cell phenotype, BCL6 gene rearrangement and poor prognosis [J] . Ana Mozos, Hongtao Ye, Wen-Yu Chuang, Modern Pathology . 2009,第9期

机译：大多数主要肾上腺淋巴瘤是弥漫性大B细胞淋巴瘤，具有非生发中心B细胞表型，BCL6基因重排和预后差
2. Clinical Significance of BCL2 , C- MYC , and BCL6 Genetic Abnormalities, Epstein-Barr Virus Infection, CD5 Protein Expression, Germinal Center B Cell/Non-Germinal Center B-Cell Subtypes, Co-expression of MYC/BCL2 Proteins and Co-expression of MYC/BCL2/BCL6 Proteins in Diffuse Large B-Cell Lymphoma: A Clinical and Pathological Correlation Study of 120 Patients [J] . Choo-Yuen Ting, Kian-Meng Chang, Jew-Win Kuan, International Journal of Medical Sciences . 2019,第4期

机译：BCL2，C-MYC和BCL6遗传异常，爱泼斯坦-巴尔病毒感染，CD5蛋白表达，生发中心B细胞/非生发中心B细胞亚型，MYC / BCL2蛋白的共表达和共表达的临床意义弥漫性大B细胞淋巴瘤中MYC / BCL2 / BCL6蛋白的表达：120例患者的临床和病理相关性研究
3. Patients with localized primary non-tonsillar oral diffuse large B-cell lymphoma exhibit favorable prognosis despite a non-germinal center B-cell-like phenotype. [J] . Sato Y, Onishi N, Morito T Cancer science. . 2009,第1期

机译：尽管存在非生发中心B细胞样表型，但局部原发性非扁桃体口腔弥漫性大B细胞淋巴瘤患者预后良好。
4. Expression profile of HIP1R in B-cell subsets and in silico prediction of its functions in diffuse large B-cell lymphoma [C] . Kah Keng Wong, Alison H Banham International Conference on Intelligent Informatics and Biomedical Sciences . 2018

机译：HIP1R在B细胞亚群中的表达特征及其在弥漫性大B细胞淋巴瘤中的功能的计算机预测
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. Clinical Significance of BCL2 C-MYC and BCL6 Genetic Abnormalities Epstein-Barr Virus Infection CD5 Protein Expression Germinal Center B Cell/Non-Germinal Center B-Cell Subtypes Co-expression of MYC/BCL2 Proteins and Co-expression of MYC/BCL2/BCL6 Proteins in Diffuse Large B-Cell Lymphoma: A Clinical and Pathological Correlation Study of 120 Patients [O] . Choo-Yuen Ting, Kian-Meng Chang, Jew-Win Kuan, 2019

机译：BCL2C-MYC和BCL6遗传异常爱泼斯坦-巴尔病毒感染CD5蛋白表达生发中心B细胞/非生发中心B细胞亚型MYC / BCL2蛋白的共表达和共表达的临床意义弥漫性大B细胞淋巴瘤中MYC / BCL2 / BCL6蛋白的表达：120例患者的临床和病理相关性研究
7. High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology [O] . David W. Scott, Rebecca L. King, Annette M. Staiger, 2018

机译：高级B细胞淋巴瘤，具有Myc和Bcl2和/或Bcl6重排，弥漫性大B细胞淋巴瘤形态

Most primary adrenal lymphomas are diffuse large B-cell lymphomas with non-germinal center B-cell phenotype, BCL6 gene rearrangement and poor prognosis

著录项

相似文献

相关主题

期刊订阅